On Jun. 26, 2020, the COVID-19 Therapeutics Accelerator donors and partners announced the formation of the International COVID-19 Data Research Alliance to accelerate clinical research on COVID-19.

Composed of academic institutions, research organizations, life sciences and technology companies, and philanthropies, the International Alliance was created to fight the COVID-19 pandemic, but with the promise for use across other health conditions, including readiness for future pandemics.